Last reviewed · How we verify

NCT05490160

Alteration of Thrombelastography and Coagulation Function in Patients Undergoing Total Knee Arthroplasty With Intra-articular Tranexamic Acid Administration

Status unknown Last updated 5 August 2022
What this trial tests

trial testing Tranexamic acid in Arthropathy of Knee in 54 participants. Status unknown.

Timeline
5 August 2022
Primary endpoint
20 August 2022
28 August 2022

Quick facts

Lead sponsorRenJi Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment54
Start date5 August 2022
Primary completion20 August 2022
Estimated completion28 August 2022

Drugs / interventions tested

Conditions studied

Sponsor

RenJi Hospital

Who can join

Eligibility, any sex, with Arthropathy of Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim and scope of this study is making comparison about the thrombelastography and coagulation function in patients before and after the total knee arthroplasty with intra-articular tranexamic acid administration. The results may identify the influence of the intra-articular tranexamic acid administration on the relative coagulability monitoring.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Tranexamic acid

Trials testing the same drug.

Other recruiting trials for Arthropathy of Knee

Currently open trials in the same condition.

Other RenJi Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05490160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing